Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16026)	9/3/2002 10:52:52 AM
From: aknahow	Read Replies (3) \| Respond to of 17367

Talking up something is the last thing shareholders need. Information about what has actually been done or being done yes, telling the world about the potential of bpi and Neuprex, no! Telcoms talked a lot of people out of their money. Making real deals takes time. Anyone can sign a quick deal if they are desperate enough to be willing to give away the store. Robert, face facts, management does not care that I urge shareholders to vote against them. They care even less that you are impatient. Sell your remaining few shares of Xoma and buy more high tech and refer me to the post where you tell them you are impatient. My point is Xoma has not been talking, you are. Your post complains about them talking not acting but at the same time whines about Xoma not talking up BPI. Grow up! Xoma has acted. Meningococcemia, Trauma, Allergan, Baxter, Crohn's, Joslin and countless research projects on BPI. Have the actions produced the results we all want apparently not, but in no way can one say they have not acted.